JPS55113721A - Immunity regulator - Google Patents
Immunity regulatorInfo
- Publication number
- JPS55113721A JPS55113721A JP2130379A JP2130379A JPS55113721A JP S55113721 A JPS55113721 A JP S55113721A JP 2130379 A JP2130379 A JP 2130379A JP 2130379 A JP2130379 A JP 2130379A JP S55113721 A JPS55113721 A JP S55113721A
- Authority
- JP
- Japan
- Prior art keywords
- immunity
- mecobalamin
- cancers
- regulator
- infectious
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000036039 immunity Effects 0.000 title abstract 5
- 229960005321 mecobalamin Drugs 0.000 abstract 3
- JEWJRMKHSMTXPP-BYFNXCQMSA-M methylcobalamin Chemical compound C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O JEWJRMKHSMTXPP-BYFNXCQMSA-M 0.000 abstract 3
- 235000007672 methylcobalamin Nutrition 0.000 abstract 3
- 239000011585 methylcobalamin Substances 0.000 abstract 3
- 208000035473 Communicable disease Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
Landscapes
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2130379A JPS55113721A (en) | 1979-02-27 | 1979-02-27 | Immunity regulator |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2130379A JPS55113721A (en) | 1979-02-27 | 1979-02-27 | Immunity regulator |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS55113721A true JPS55113721A (en) | 1980-09-02 |
| JPS6352014B2 JPS6352014B2 (enrdf_load_stackoverflow) | 1988-10-17 |
Family
ID=12051371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2130379A Granted JPS55113721A (en) | 1979-02-27 | 1979-02-27 | Immunity regulator |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS55113721A (enrdf_load_stackoverflow) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002533399A (ja) * | 1998-12-28 | 2002-10-08 | アラジー リミテッド エルエルシー | アレルギー性疾患に対するシアノコバラミン（ビタミンｂ１２）の治療方法 |
| US6787527B1 (en) * | 1994-11-10 | 2004-09-07 | Duke University | Methods of preventing and treating HIV infection |
| WO2004098614A1 (ja) * | 2003-05-07 | 2004-11-18 | Eisai Co., Ltd. | メチルコバラミン含有凍結乾燥製剤及びその製造方法 |
| DE102010023626A1 (de) * | 2010-06-14 | 2011-12-15 | Thomas Schütz | Verwendung von Corrinoiden zur arzneilichen Anwendung bei Fell- und Hauterkrankungen bei Klein- und Groß-Tieren (warm- und kaltblütig), (z.B. bei Fischen, Vögeln, Pferden, Rindern, Kamelen, Hunden, Katzen, Reptilien) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02131115U (enrdf_load_stackoverflow) * | 1989-03-31 | 1990-10-31 |
-
1979
- 1979-02-27 JP JP2130379A patent/JPS55113721A/ja active Granted
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6787527B1 (en) * | 1994-11-10 | 2004-09-07 | Duke University | Methods of preventing and treating HIV infection |
| JP2002533399A (ja) * | 1998-12-28 | 2002-10-08 | アラジー リミテッド エルエルシー | アレルギー性疾患に対するシアノコバラミン（ビタミンｂ１２）の治療方法 |
| WO2004098614A1 (ja) * | 2003-05-07 | 2004-11-18 | Eisai Co., Ltd. | メチルコバラミン含有凍結乾燥製剤及びその製造方法 |
| JPWO2004098614A1 (ja) * | 2003-05-07 | 2006-07-13 | エーザイ株式会社 | メチルコバラミン含有凍結乾燥製剤及びその製造方法 |
| KR100732100B1 (ko) * | 2003-05-07 | 2007-06-27 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 메틸코발라민 함유 동결 건조 제제 및 그의 제조 방법 |
| CN100376251C (zh) * | 2003-05-07 | 2008-03-26 | 卫材R&D管理有限公司 | 含有甲基维生素b12的冻干制剂及其制备方法 |
| JP4753717B2 (ja) * | 2003-05-07 | 2011-08-24 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | メチルコバラミン含有凍結乾燥製剤及びその製造方法 |
| DE102010023626A1 (de) * | 2010-06-14 | 2011-12-15 | Thomas Schütz | Verwendung von Corrinoiden zur arzneilichen Anwendung bei Fell- und Hauterkrankungen bei Klein- und Groß-Tieren (warm- und kaltblütig), (z.B. bei Fischen, Vögeln, Pferden, Rindern, Kamelen, Hunden, Katzen, Reptilien) |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6352014B2 (enrdf_load_stackoverflow) | 1988-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0154344A3 (en) | Antiviral pharmaceutical preparations and methods for their use | |
| ATE22562T1 (de) | 6-substituierte s-triazolo(3,4-a)phthalazinderivate. | |
| EG19409A (en) | Improvements relating to the processing of tobacco leaves. | |
| IT8320369A0 (it) | Struttura antiurto protettiva per parti del corpo umano. | |
| ZA871528B (en) | The treatment of diseases of the immune system with diphenylhydantoin and its derivatives | |
| IT1208480B (it) | Agente per intensificare l'azione antitumorale di un agente antitumorale. | |
| DE3369682D1 (en) | 2-substituted 1-aminoalkyl-1,2,3,4-tetrahydro-beta-carbolines, their preparation and use as medicaments | |
| DE3277726D1 (en) | Use of alkaloid derivatives for the manufacture of a medicament for the strengthening of the immune system and for the treatment of viral, bacterial and fungal infections | |
| MY128260A (en) | Cyclopentane-and-pentene-b-amino acids | |
| ZA845670B (en) | Coumarin derivatives,pharmaceutical compositions containing the same,and the use thereof in the treatment of cancer | |
| DK0531413T3 (da) | Et antiviralt præparat indeholdende prostratin | |
| EP0325129A3 (en) | Disubstituted pyridines | |
| ZA876435B (en) | The use of scr's in extended retarding | |
| JPS55113721A (en) | Immunity regulator | |
| ZA835360B (en) | Use of sugar derivatives for the prophylaxis and treatment of virus infections | |
| AU1332176A (en) | Detection, and'Prevention of Diseases caused by N, Gonorrhoeae | |
| DE3260932D1 (en) | Process for the preparation of derivatives of resorcin, and the use of certain derivatives of resorcin as perfumes | |
| FR2620163B1 (fr) | Blindage notamment pour coffre-fort et coffre-fort s'y rapportant | |
| DE3163920D1 (en) | Pharmaceutical preparations comprising polyprenyl compounds, especially as anti-cancer agents, and pharmaceutical compositions for the prevention and treatment of cancer and skin diseases | |
| PH17779A (en) | 2,4-diaminopyrimidine derivatives processing anti-malarial properties,processes for their preparation and compositions containing them | |
| FI851365A0 (fi) | Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel. | |
| EP0452360A4 (en) | Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections | |
| IT1150759B (it) | Complessi organometallici di n-cicloesil-piperazino-acetammidi o propionammidi, loro preparazione e impiego come farmaci antiulcera-antisecretivi-tamponanti | |
| JPS5248626A (en) | Disaccharide derivatives and their preparation process | |
| JPS5639019A (en) | Antiviral agent |